Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin honey oral gel for chemotherapy-induced oral mucositis
IRCT20240723062520N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of erythropoietin in stomatitis (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoint: Favorable therapeutic effects on oral lesions caused by chemotherapy. Started Jul 2024; status: completed.
02
Drugs
erythropoietin
03
Conditions
stomatitis
Beyond the preview
Go deeper on IRCT20240723062520N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240723062520N1.